Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Pharmacology|July 16, 2019
Therapeutic drug monitoring-based dosing of TNF inhibitors in inflammatory bowel disease: the way forward?Anne S Strik, Sophie E Berends, Mark Löwenberg
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Golimumab for moderate to severe ulcerative colitisAnne S Strik, Sophie E Berends, Ron A Mathôt, et al.
Clinical Pharmacokinetics|May 13, 2018
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative ColitisSophie E Berends, Anne S Strik, Mark Löwenberg, et al.
Journal of Forensic Sciences|December 17, 2013
Pneumomediastinum and soft tissue emphysema in pediatric hangingTessa Sieswerda-Hoogendoorn, Anne S Strik, Nick F J Hilgersom, et al.
The AAPS Journal|September 7, 2018
Individualized Dosing of Therapeutic Monoclonal Antibodies-a Changing Treatment Paradigm?Anne S Strik, Yow-Ming C Wang, Laura E Ruff, et al.
Scandinavian Journal of Gastroenterology|April 30, 2019
Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patientsAnne S Strik, Mark Löwenberg, Christianne J Buskens, et al.
Therapeutic Drug Monitoring|March 13, 2018
Explaining Interpatient Variability in Adalimumab Pharmacokinetics in Patients With Crohn's DiseaseSophie E Berends, Anne S Strik, Juliet C Van Selm, et al.
Therapeutic Drug Monitoring|August 30, 2019
Monitoring of Adalimumab Concentrations at Home in Patients with Inflammatory Bowel Disease Using Dried Blood SamplesSophie E Berends, Karien Bloem, Annick de Vries, et al.
Scandinavian Journal of Gastroenterology|May 28, 2019
Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC studySophie E Berends, Anne S Strik, Jeroen M Jansen, et al.
Pageof 2